Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)

What a subscription adds to this notice

• The documents — every attachment, with its text extracted and searchable
• Qualification — the notice scored against your company profile
• Tracking and alerts — a pipeline for your bids, and the matching notices by email
• The API and MCP — the same record in your own tools and your AI assistant